Oncology Research Editorial Office

Oncology Research, Vol.34, No.5, 2026, DOI:10.32604/or.2026.081624 - 22 April 2026

Abstract This article has no abstract. More >

Oncology Research Editorial Office

Oncology Research, Vol.34, No.5, 2026, DOI:10.32604/or.2026.081623 - 22 April 2026

Abstract This article has no abstract. More >

Oncology Research Editorial Office

Oncology Research, Vol.34, No.5, 2026, DOI:10.32604/or.2026.081621 - 22 April 2026

Abstract This article has no abstract. More >

Dimitra P. Vageli^1,2,3,4,*, Panagiotis G. Doukas⁵, Nikolaos Papageorgiou¹, Chrysanthi A. Markou¹, Konstantina Zacharouli¹, Maria Ioannou^1,6

Oncology Research, Vol.34, No.5, 2026, DOI:10.32604/or.2026.077195 - 22 April 2026

Abstract Background: Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults, with a poor prognosis in advanced stages. Although histological tumor grading is an established prognostic parameter, it often fails to capture the biological heterogeneity of RCC. Therefore, identifying novel biomarkers could enhance early diagnosis and improve predictive accuracy. Here, we aimed to test whether immunophenotypes of specific glutathione peroxidase (GPX) family members may have prognostic value in RCC. Methods: We investigated the relationship between GPX1 and GPX3 immunophenotypes and clinicopathological parameters in 32 surgical specimens of clear cell RCC (ccRCC)… More >

Chunhui Tian^1,2, Weipin Xie^1,2, Wen Li², Huaiyu Gu², Xuebao Liu², Busheng Tong^1,*, Yehai Liu^1,*, Huaiyuan Zong^3,*

Oncology Research, Vol.34, No.5, 2026, DOI:10.32604/or.2026.077171 - 22 April 2026

Abstract Background: In head and neck squamous cell carcinoma (HNSCC), solute carrier family 16 member 1 (SLC16A1) is associated with tumor advancement and reduced sensitivity to ferroptosis, yet the molecular basis of these effects remains unclear. This study seeks to uncover how SLC16A1 contributes to HNSCC tumorigenesis. Methods: To elucidate how SLC16A1 drives HNSCC progression via ferroptosis resistance, we performed RNA sequencing on SLC16A1-knockdown HNSCC cells and controls, followed by functional validation. We next systematically assessed the role of the candidate molecule solute carrier family 7 member 11 (SLC7A11) in HNSCC progression and resistance to ferroptosis… More > Graphic Abstract

Cong Liu¹, Zhenyu Zhang¹, Ronghua Feng¹, Mengsi Zeng¹, Hui Li¹, Mei Zhu¹, Lan Zhuang^2,*, Zongjuan Li^1,*, Tao Wu^1,*

Oncology Research, Vol.34, No.5, 2026, DOI:10.32604/or.2026.077059 - 22 April 2026

Abstract Background: Breast cancer is the leading cause of cancer-related deaths in women, primarily due to distant metastasis. Metabolic reprogramming plays a critical role in tumor growth and spread, but the metabolic mechanisms underlying metastasis in breast cancer remain unclear. The primary objective of this study is to identify molecular targets mediating breast cancer progression and to evaluate whether targeting the metabolic reprogramming represents a potential therapeutic strategy. Methods: To uncover key metabolic regulators involved in breast cancer progression, we analyzed high-throughput RNA sequencing data and identified Paired Like Homeodomain 1 (PITX1) as a frequently upregulated… More >

Jarosław Nuszkiewicz^1,*, Joanna Wróblewska¹, Marek Jóźwiak², Marta Pawłowska¹

Oncology Research, Vol.34, No.5, 2026, DOI:10.32604/or.2026.077020 - 22 April 2026

Abstract Melatonin, an endogenous indoleamine primarily synthesized in the pineal gland, has emerged as a promising adjunctive agent within integrative oncology due to its pleiotropic biological actions. Beyond its well-known chronobiological functions, melatonin exerts potent redox-regulatory, anti-inflammatory, oncostatic, and immune-modulating effects that are relevant across multiple stages of carcinogenesis and cancer therapy. Oxidative stress (OS), defined as an imbalance between reactive oxygen and nitrogen species (ROS/RNS) generation and antioxidant defenses, plays a central role in DNA damage, protein adduct formation, and lipid peroxidation, ultimately contributing to mutation accumulation, treatment resistance, and tumor progression. Melatonin modulates these… More >

Ashuai Du^1,#, Dianbin Guo^2,#, Dongbo Yuan^3,#, Kai Li⁴, Yuanyuan Luo⁴, Songsong Tan³, Xuchao Dai⁴, Bo Yu⁵, Wanxiang You⁶, Junjie Zhao⁷, Bo Yan³, Kehua Jiang^3,*, Xiaofei Fan^2,*, Jianguo Zhu^3,*,*

Oncology Research, Vol.34, No.5, 2026, DOI:10.32604/or.2026.076716 - 22 April 2026

Abstract Background: Bisphenol A (BPA) is a widely used industrial chemical and endocrine-disrupting compound, and accumulating evidence suggests that it may contribute to prostate cancer progression; however, the underlying molecular mechanisms remain incompletely elucidated. This study aimed to elucidate the molecular targets and signaling pathways underlying BPA-induced prostate cancer progression. Methods: In this study, an integrated strategy combining network toxicology, molecular docking, and molecular dynamics simulations was employed to identify potential BPA-related targets and signaling pathways involved in prostate cancer. Candidate targets were retrieved from public databases, followed by protein-protein interaction network analysis to screen key… More >

Lu Hao^1,#, Jiao Lu^2,#, Jisu Xue^2,*

Oncology Research, Vol.34, No.5, 2026, DOI:10.32604/or.2026.076420 - 22 April 2026

Abstract In vivo Chimeric Antigen Receptor (CAR)-T cell therapy reprograms a patient’s own T cells directly inside the body, bypassing the complex and costly traditional manufacturing process. This is achieved by systemically delivering viral or non-viral vectors that genetically modify endogenous T lymphocytes to produce functional CAR-T cells de novo. By eliminating ex vivo cell processing, this strategy can simplify workflows, reduce costs, improve accessibility, and allow faster treatment. Key delivery platforms include engineered lentiviral and adeno-associated viral (AAV) vectors for lasting CAR expression and targeted lipid nanoparticles (LNPs) for transient mRNA delivery. Emerging technologies like biomaterial scaffolds and… More >

Nevena Todorovic^1,#, Sara Bertorello^1,#, Giulia Nannini¹, Serena Pillozzi², Simonetta Bianchi³, Maria Raffaella Ambrosio⁴, Elena Niccolai¹, Simone Baldi¹, Amedeo Amedei^1,*

Oncology Research, Vol.34, No.5, 2026, DOI:10.32604/or.2026.076380 - 22 April 2026

Abstract Background: Cancer remains one of the leading global health challenges, with lung cancer (LC), breast cancer (BC), and colorectal cancer (CRC) among the most prevalent and deadly malignancies. The intratumoral microbiota (IM), a distinct microbial ecosystem within tumor tissues, has recently emerged as a potential modulator of carcinogenesis, immune responses, and metastatic progression. However, comparative cross-cancer analyses remain limited. Therefore, this study aimed to compare the IM across these cancer types, with particular emphasis on distinguishing metastatic from non-metastatic malignancies, to identify tumor-specific microbial signatures with potential relevance for biomarker discovery, patient stratification, and microbiota-informed… More >